Evidence map›Paper›PMID 24737505›Full record

ArticlePsychopharmacology2014

Rasgrf2 controls noradrenergic involvement in the acute and subchronic effects of alcohol in the brain.

Alanna C Easton, Andrea Rotter, Anbarasu Lourdusamy, Sylvane Desrivières, Alberto Fernández-Medarde, Teresa Biermann, Cathy Fernandes, Eugenio Santos, Johannes Kornhuber, Gunter Schumann and 1 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Psychopharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Ras GEF Mouse Models for the Analysis of Ras Biology and Signaling.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  7. Neural basis of reward anticipation and its genetic determinants.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Alanna C EastonMRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, De Crespigny Park, London, SE5 8AF, UK.
Andrea Rotter
Anbarasu Lourdusamy
Sylvane Desrivières
Alberto Fernández-Medarde
Teresa Biermann
Cathy Fernandes
Eugenio Santos
Johannes Kornhuber
Gunter Schumann
Christian P Müller
King's College London · GBFriedrich-Alexander-Universität Erlangen-Nürnberg · DECentro de Investigación del Cáncer · ESUniversidad de Salamanca · ES

Funding

Medical Research Council G0901858
6 · The paper itself

Abstract

rationaleAlcohol addiction is a major psychiatric disease, and yet, the underlying molecular adaptations in the brain remain unclear. Recent evidence suggests a functional role for the ras-specific guanine-nucleotide releasing factor 2 (Rasgrf2) in alcoholism. Rasgrf2(-/-) mice consume less alcohol and show entirely absent dopamine responses to an alcohol challenge compared to wild types (WT).

objectiveIn order to further investigate how Rasgrf2 modifies the acute and subchronic effects of alcohol in the brain, we investigated its effects on the noradrenergic and serotonergic systems.

methodsWe measured noradrenaline and serotonin activity in the brain by in vivo microdialysis and RNA expression by chip analysis and RT-PCR after acute and sub-chronic alcohol exposure in Rasgrf2(-/-) and WT mice.

resultsIn vivo microdialysis showed a significantly reduced noradrenergic response and an absent serotonergic response in the nucleus accumbens (NAcc) and caudate putamen (CPu) after an alcohol challenge in Rasgrf2(-/-) mice. A co-expression analysis showed that there is a high correlation between Rasgrf2 and α2 adrenoceptor RNA expression in the ventral striatum in naïve animals. Accordingly, we further assessed the role of Rasgrf2 in the response of the noradrenergic system to subchronic alcohol exposure. A decrease in β1 adrenoceptor gene expression was seen in Rasgrf2(+/+), but not Rasgrf2(-/-) mice following alcohol exposure. Conversely, alcohol resulted in a decrease in both β2 and α2 adrenoceptor gene expression in knockout but not WT Rasgrf2 mice.

conclusionsThese findings suggest that adaptations in the noradrenergic system contribute to the Rasgrf2 enhanced risk of alcoholism.

Indexed as

AlcoholismAnimalsBrainDopamineEthanolGene ExpressionMiceMice, KnockoutMicrodialysisNorepinephrineNucleus Accumbensras Guanine Nucleotide Exchange FactorsReceptors, Adrenergic, alpha-2Receptors, Adrenergic, beta-2SerotoninSignal TransductionDopamineEthanolNorepinephrineRasgrf2 protein, mouseras Guanine Nucleotide Exchange FactorsReceptors, Adrenergic, alpha-2Receptors, Adrenergic, beta-2Serotonin

Identifiers

PMID24737505
OpenAlexW2068037860

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.